Swiss government forced to halve 2023 Covid vaccine orders
A divided Swiss parliament has demanded that the government tear up orders for 14 million doses of Covid-19 vaccines and renegotiate contracts for half of this supply.
This content was published on
2 minutes
swissinfo.ch/mga
Português
pt
Governo suíço obrigado a reduzir pela metade os pedidos de vacina Covid para 2023
The extent of the order has divided parliament, with the House of Representatives agreeing with the decision but the Senate saying the combined order is excessive.
The disagreement could not be settled on Thursday, but in cases of procurement the argument that saves the state money must take precedence.
This means that the Senate prevailed in their argument, which will force the government to slash its order in half to seven million doses. This is expected to reduce the bill from CHF780 million ($780 million) to CHF560 million.
A million doses of a non-mRNA vaccine have also been ordered from another (unnamed) manufacturer.
Finance Minister Ueli Maurer warned that Switzerland might have to pay more for each dose as the same price might not be on offer now.
For 2022, 34 million doses have already been acquired – 20 million for the first half of the year and 14 million for the second. Around 70% of the population have been vaccinated.
How is your country dealing with the return of stolen artifacts?
Western nations like Switzerland often have to deal with the process of recovering or returning looted artifacts which have been illegally imported. What’s the situation like in your country?
What do you think Switzerland’s Alain Berset can bring to the Council of Europe?
The former interior minister is to become the first Swiss Secretary General of the Council of Europe – which issues should his five-year term focus on?
Sylvain Saudan, ‘skier of the impossible’, dies aged 87
This content was published on
The Swiss father of extreme skiing pioneered descents from the Alps to the Himalayas – and became the sport’s first star.
Hayek family buys additional Swatch shares for nearly CHF11 million
This content was published on
Following the acquisition of registered shares worth over CHF20.6 million on Monday, the Hayek family made another purchase on Tuesday.
Suicide capsule to be used in Switzerland this year, says euthanasia organisation
This content was published on
The organisation “The Last Resort” has confirmed that the suicide capsule Sarco is to be used in Switzerland. This should happen this year, it said.
Ukrainian children flown to Switzerland for cancer treatment
This content was published on
The Swiss air rescue service Rega flew two Ukrainian children with cancer to Switzerland from a hospital in Kyiv hit by Russian missiles.
Swiss Solidarity raises over CHF10 million for victims of extreme weather
This content was published on
The money raised will be used to help those affected by the recent storms and flooding in the cantons of Ticino, Graubünden, and Valais.
Swiss giant Roche given green light for lung cancer drug in Canada
This content was published on
According to a recent study, Roche’s Alecensaro reduced the risk of recurrence or death by 76% compared to chemotherapy alone.
Swiss luxury watch market hit hard by China-led slump
This content was published on
Sales of Swiss-made luxury watches are in sharp retreat as nervous consumers reconsider splashing out on expensive timepieces and demand slumps.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland orders 14 million Covid-19 vaccines for 2023
This content was published on
Switzerland is buying at least 14 million doses of Covid-19 vaccine for 2023, in order to be ready for “all pandemic scenarios”.
This content was published on
Covid case rates are rising again across much of the Western world in countries like France, Germany, Britain and Switzerland, but also in Asia.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.